Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

dc.contributor.author Agustí García-Navarro, Àlvar
dc.contributor.author Pascual Guàrdia, Sergi, 1979-
dc.contributor.author Faner, Rosa
dc.date.accessioned 2022-09-19T06:18:53Z
dc.date.available 2022-09-19T06:18:53Z
dc.date.issued 2022
dc.format.mimetype application/pdf
dc.identifier.citation Agustí A, De Stefano G, Levi A, Muñoz X, Romero-Mesones C, Sibila O et al. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. Eur Respir J. 2022 Mar 10;59(3):2103036. DOI: 10.1183/13993003.03036-2021
dc.identifier.doi http://dx.doi.org/10.1183/13993003.03036-2021
dc.identifier.issn 0903-1936
dc.identifier.uri http://hdl.handle.net/10230/54098
dc.language.iso eng
dc.publisher European Respiratory Society
dc.relation.ispartof Eur Respir J. 2022 Mar 10;59(3):2103036
dc.rights © The authors 2022. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For reproduction rights and permissions contact permissions@ersnet.org
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
dc.title Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
dc.type info:eu-repo/semantics/article
dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions